XML 54 R46.htm IDEA: XBRL DOCUMENT
v3.25.0.1

STOCK-BASED COMPENSATION (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |  |
SCHEDULE OF STOCK OPTIONS OUTSTANDING | A summary of all stock option activity under the Plans for the nine months ended September 30, 2024 is as follows: SCHEDULE OF STOCK OPTIONS OUTSTANDING
Options |  | Number of Shares |  |  | Weighted Average Exercise Price |
Outstanding at December 31, 2023 |  |  | 53,600 |  |  | $ | 45.55 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Forfeited/expired |  |  | (1,100 | ) |  |  | (65.00 | )
Outstanding at September 30, 2024 |  |  | 52,500 |  |  | $ | 45.14 |
Exercisable at September 30, 2024 |  |  | 52,500 |  |  | $ | 45.14 |
| Activity in the various Plans during the years ended December 31, 2023 and 2022 is reflected in the following table: SUMMARY OF STOCK OPTIONS OUTSTANDING
Options |  | Number of Shares |  |  | Weighted Average Exercise Price |
Outstanding at January 1, 2022 |  |  | 54,303 |  |  | $ | 47.40 |
Granted |  |  | 1,250 |  |  |  | 19.60 |
Exercised |  |  | - |  |  |  | - |
Forfeited |  |  | (1,603 | ) |  |  | (80.80 | )
Outstanding at December 31, 2022 |  |  | 53,950 |  |  | $ | 45.80 |
Exercisable at December 31, 2022 |  |  | 53,950 |  |  | $ | 45.80 |
Options |  | Number of Shares |  |  | Weighted Average Exercise Price |
Outstanding at January 1, 2023 |  |  | 53,950 |  |  | $ | 45.80 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Forfeited |  |  | (350 | ) |  |  | (83.20 | )
Outstanding at December 31, 2023 |  |  | 53,600 |  |  | $ | 45.55 |
Exercisable at December 31, 2023 |  |  | 53,600 |  |  | $ | 45.55 |
SCHEDULE OF FAIR VALUE OF STOCK OPTIONS ASSUMPTION |  | The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated grant date fair value of the options during the years ended December 31, 2023 and 2022: SCHEDULE OF FAIR VALUE OF STOCK OPTIONS ASSUMPTION
|  | 2023 |  |  | 2022 |
|  | Assumptions |  |  | Assumptions |
Volatility - range |  |  | - |  |  |  | 111.67 | %
Risk-free rate |  |  | - |  |  |  | 1.81 | %
Expected term |  |  | - |  |  |  | 10.0 years |
Exercise price |  |  | - |  |  | $ | 19.60 |
SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE | The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of September 30, 2024: SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE
|  |  |  | Outstanding options |  |  | Exercisable options |
Exercise price range |  |  | Number of options |  |  | Weighted average remaining contractual life |  |  | Number of options |  |  | Weighted average remaining contractual life |
$ | 0.01 to $49.99 |  |  |  | 37,000 |  |  |  | 5.9 years |  |  |  | 37,000 |  |  |  | 5.9 years |
$ | 50.00 to $69.99 |  |  |  | 14,000 |  |  |  | 4.0 years |  |  |  | 14,000 |  |  |  | 4.0 years |
$ | 70.00 to $89.99 |  |  |  | 1,500 |  |  |  | 1.6 years |  |  |  | 1,500 |  |  |  | 1.6 years |
|  |  |  |  | 52,500 |  |  |  | 5.2 years |  |  |  | 52,500 |  |  |  | 5.2 years |
| The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of December 31, 2023: SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE
|  |  | Outstanding options |  |  | Exercisable options |
Exercise price range |  |  | Number of options |  |  | Weighted average remaining contractual life |  |  | Number of options |  |  | Weighted average remaining contractual life |
$ | 0.01 to $49.99 |  |  |  | 37,000 |  |  |  | 6.6 years |  |  |  | 37,000 |  |  |  | 6.6 years |
$ | 50.00 to $69.99 |  |  |  | 15,100 |  |  |  | 4.5 years |  |  |  | 15,100 |  |  |  | 4.5 years |
$ | 70.00 to $89.99 |  |  |  | 1,500 |  |  |  | 2.4 years |  |  |  | 1,500 |  |  |  | 2.4 years |
|  |  |  |  | 53,600 |  |  |  | 5.9 years |  |  |  | 53,600 |  |  |  | 5.9 years |
SCHEDULE OF RESTRICTED STOCK ACTIVITY | A summary of all restricted stock activity under the Plans for the nine months ended September 30, 2024 is as follows: SCHEDULE OF RESTRICTED STOCK ACTIVITY
|  | Number of Restricted shares |  |  | Weighted average grant date fair value |
Nonvested balance, December 31, 2023 |  |  | 53,875 |  |  | $ | 11.27 |
Granted |  |  | 80,197 |  |  |  | 2.12 |
Vested |  |  | (32,250 | ) |  |  | (10.87 | )
Forfeited |  |  | (51,072 | ) |  |  | (2.91 | )
Nonvested balance, September 30, 2024 |  |  | 50,750 |  |  | $ | 5.48 |
| A summary of all restricted stock activity under the equity compensation plans for the years ended December 31, 2023 and 2022 is as follows: SUMMARY OF RESTRICTED STOCK ACTIVITY
|  | Number of Restricted shares |  |  | Weighted average grant date fair value |
Nonvested balance, January 1, 2022 |  |  | 52,869 |  |  | $ | 37.40 |
Granted |  |  | 60,750 |  |  |  | 14.67 |
Vested |  |  | (31,244 | ) |  |  | (34.73 | )
Forfeited |  |  | (3,250 | ) |  |  | (21.20 | )
Nonvested balance, December 31, 2022 |  |  | 79,125 |  |  | $ | 21.73 |
|  | Number of Restricted shares |  |  | Weighted average grant date fair value |
Nonvested balance, January 1, 2023 |  |  | 79,125 |  |  | $ | 21.73 |
Granted |  |  | 35,000 |  |  |  | 5.00 |
Vested |  |  | (56,625 | ) |  |  | (21.29 | )
Forfeited |  |  | (3,625 | ) |  |  | (22.41 | )
Nonvested balance, December 31, 2023 |  |  | 53,875 |  |  | $ | 11.27 |
SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK | The nonvested balance of restricted stock vests as follows: SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK
Years ended |  | Number of Shares |
2024 (October 1, 2024 through December 31, 2024) |  |  | - |
2025 |  |  | 35,250 |
2026 |  |  | 6,500 |
2027 |  |  | 5,000 |
2028 |  |  | 4,000 |
| The nonvested balance of restricted stock vests as follows: SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK
Years ended |  | Number of shares |
2024 |  |  | 27,750 |
2025 |  |  | 19,000 |
2026 |  |  | 4,125 |
2027 |  |  | 2,000 |
2028 |  |  | 1,000 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration